Fig. 5.
Fig. 5. Expression of CD86 antigen in rhGM-CSF–treated M1 cells expressing α or βc subunits, or both, of GM-CSF receptor. / Cells were incubated with rhGM-CSF 100 ng/mL for 3 days, then analyzed by flow cytometry using anti-CD86 or an irrelevant isotype-matched control antibody. (A) Bars show mean ± SD of D/s(n) (derived from Kolmogorov-Smirnoff analysis) of 3 independent derived pools. (B) Histograms of CD86 fluorescence with and without rhGM-CSF treatment in M1/βc/α-1 (left) and M1/βc/α-2 (right) cells.

Expression of CD86 antigen in rhGM-CSF–treated M1 cells expressing α or βc subunits, or both, of GM-CSF receptor.

Cells were incubated with rhGM-CSF 100 ng/mL for 3 days, then analyzed by flow cytometry using anti-CD86 or an irrelevant isotype-matched control antibody. (A) Bars show mean ± SD of D/s(n) (derived from Kolmogorov-Smirnoff analysis) of 3 independent derived pools. (B) Histograms of CD86 fluorescence with and without rhGM-CSF treatment in M1/βc/α-1 (left) and M1/βc/α-2 (right) cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal